Marcacine Karla Oliveira, Abuchaim Erika de Sá Vieira, Coca Kelly Pereira, Abrão Ana Cristina Freitas de Vilhena
Universidade Federal de São Paulo, Escola Paulista de Enfermagem, Departamento de Enfermagem em Saúde da Mulher, São Paulo, Brasil.
Rev Esc Enferm USP. 2018 Oct 11;52:e03363. doi: 10.1590/S1980-220X2017037803363.
To analyze the association between the surgical characteristics of breast implants, time elapsed since surgery, access route, implant placement and implanted volume and variables related to breastfeeding, type, first 'milk let-down', breast engorgement, pain, lesion, milk production and use of galactagogues.
A prospective cohort carried out during the hospital stay (12 to 72 hours after delivery), home care (5thto 7thday after delivery) and telephone contact (between the 30thand 32ndday postpartum) of 115 postpartum women with breast implants between 2015 and 2017.
The first evaluation identified more frequent use of oral galactagogues (p=0.029) by puerperal women with prepectoral implants, and of oxytocin spray by those with implants up to 270 ml (p=0.040). The second evaluation showed a higher pain score among those with prepectoral implants (p=0.046). Around the 30thday postpartum, the presence of nipple lesion (p=0.021), pain (p=0.025) and a higher pain score (p=0.039) was more frequent among those with mammoplasty performed less than 10 years ago.
The presence of pain and a higher pain score, the occurrence of lesion and the use of oral and nasal galactagogues were associated with implant placement, implant size and time elapsed since surgery.
分析乳房植入物的手术特征、手术时间、入路、植入位置和植入量与母乳喂养相关变量(类型、首次“下奶”、乳房胀痛、疼痛、损伤、产奶量及催乳剂使用情况)之间的关联。
对2015年至2017年间115例产后植入乳房假体的女性进行前瞻性队列研究,研究在住院期间(分娩后12至72小时)、家庭护理(分娩后第5至7天)以及电话随访(产后第30至32天)期间开展。
首次评估发现,胸前植入假体的产妇更频繁使用口服催乳剂(p = 0.029),植入量达270毫升的产妇更频繁使用催产素喷雾剂(p = 0.040)。第二次评估显示胸前植入假体的产妇疼痛评分更高(p = 0.046)。在产后第30天左右,手术时间不到10年的乳房成形术患者中,乳头损伤(p = 0.021)、疼痛(p = 0.025)及更高的疼痛评分(p = 0.039)更为常见。
疼痛及更高的疼痛评分、损伤的发生以及口服和鼻用催乳剂的使用与植入位置、植入物大小及手术时间有关。